EOM Pharmaceutical Holdings Inc (IMUC)
0.1421
0.00 (0.00%)
USD |
OTCM |
Apr 15, 16:00
EOM Pharmaceutical Holdings Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.0013M |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | -0.004M |
| December 31, 2015 | 0.00 |
| September 30, 2015 | -0.1633M |
| June 30, 2015 | -0.0047M |
| March 31, 2015 | -0.0018M |
| December 31, 2014 | 0.00 |
| September 30, 2014 | -0.0254M |
| June 30, 2014 | 0.00 |
| March 31, 2014 | -0.0032M |
| December 31, 2013 | -0.0065M |
| September 30, 2013 | -0.0034M |
| June 30, 2013 | -0.0344M |
| March 31, 2013 | 0.00 |
| December 31, 2012 | -0.0042M |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
| March 31, 2012 | -0.0057M |
| Date | Value |
|---|---|
| December 31, 2011 | -0.0193M |
| September 30, 2011 | -0.0272M |
| June 30, 2011 | 0.00 |
| March 31, 2011 | -0.0379M |
| December 31, 2010 | 1.065M |
| September 30, 2010 | 0.00 |
| June 30, 2010 | 0.00 |
| March 31, 2010 | 0.00 |
| December 31, 2009 | |
| September 30, 2009 | |
| June 30, 2009 | |
| March 31, 2009 | |
| December 31, 2008 | -3.002M |
| September 30, 2008 | 0.00 |
| June 30, 2008 | -0.0062M |
| March 31, 2008 | -0.0023M |
| December 31, 2007 | 0.00 |
| September 30, 2007 | 0.00 |
| June 30, 2007 | 0.00 |
| March 31, 2007 | 0.00 |
| December 31, 2006 | 0.00 |
| September 30, 2006 | 0.00 |
| June 30, 2006 | 0.00 |
| March 31, 2006 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| CEL-SCI Corp | -0.0649M |
| AIM ImmunoTech Inc | -0.214M |
| IGC Pharma Inc | -0.061M |
| NovaBay Pharmaceuticals Inc | -0.002M |
| Protalix BioTherapeutics Inc | -0.342M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -2.174M |